Join
Live feed
·
INSIDERFilingvia Quantisnow
Neoleukin Therapeutics Inc. logo

SEC Form 4: Walkey Carl sold $7,036 worth of Common Stock (650 units at $10.82), decreasing direct ownership by 0.05% to 1,353,089 units

ByQuantisnow·Wall Street's wire, on your screen.
NLTX· Neoleukin Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NLTX (Neoleukin Therapeutics Inc.) and more on Quantisnow.